Dare Bioscience Inc —— 季度现金流量表 (NASDAQ:DARE) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 22.1 M18.62 M12.98 M30.75 M32.47 M 负债总额 28.11 M28.18 M25.71 M27.89 M29.63 M 权益总额 -6.01 M-9.56 M-12.73 M2.86 M2.84 M 负债及股东权益总额 22.1 M18.62 M12.98 M30.75 M32.47 M 总债务 ————— 净债务 —————

新闻

Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Lags Revenue Estimates

Daré Bioscience, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:DARE) 2026-03-26

Daré Bioscience获NIH延长早产药物资助期限

Daré Bioscience extends NIH grant period for preterm birth drug

Dianthus Therapeutics, Inc. (DNTH) Reports Q4 Loss, Misses Revenue Estimates

uniQure (QURE) Reports Q4 Loss, Misses Revenue Estimates

Daré Bioscience获FDA批准开展HPV治疗试验

Daré Bioscience gets FDA clearance for HPV treatment trial

达雷生物科学在纳斯达克发行优先股和权证

Dare Bioscience launches preferred stock and warrant offering on Nasdaq

H.C. Wainwright维持Dare Bioscience股票买入评级，尽管拜耳退出合作

Dare Bioscience stock maintains Buy rating at H.C. Wainwright as Bayer exits